Adolescents with Human Immunodeficiency Virus (HIV) in Botswana, South Africa, Thailand, Uganda and the United States who ...
Though an antiretroviral medication called PrEP provides near-perfect protection against HIV, patients must often surmount ...
An integrase inhibitor-based antiretroviral regimen is noninferior to a boosted protease inhibitor-based regimen in treatment ...
The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...
The study’s researchers reviewed 252 autopsy reports for adult HIV patients from Bellevue Hospital in New York City from 1984-2016. They found the patients’ mean age of death rose from 35 in 1984 to ...
Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...
Long COVID prevalence in HIV-positive individuals is estimated at 43%, with significant heterogeneity across studies. Antiretroviral therapy reduces poor COVID-19 outcomes, but long COVID effects in ...
The National AIDS and STI Control Programme (NASCOP) and the Health NGOs Network (HENNET) have issued a strong warning ...
Research into this new way of treating HIV is only beginning. When it was first named in 1983, HIV was thought to be a death sentence. The virus replicated rapidly in the people it infected because ...
Over the course of five years, the researchers studied patients with HIV-related sepsis in eastern Africa, discovering that ...
Mumbai, Jan 14: In the last five years, more than 6,800 People Living with HIV (PLHIV) have been lost to follow-up (LTFU) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results